Business Context and Reporting Period
Alphatec Holdings, Inc. filed a Form 8-K on March 7, 2019, reporting a material definitive agreement and the release of financial results for the quarter and year ended December 31, 2018.
Key Financial Metrics and Debt
The filing details a new financing arrangement but does not provide specific revenue, profit, or cash flow figures within the text of this report; those metrics are contained in an attached press release (Exhibit 99.1).
- Debt Facility: Entered into a firm letter of commitment for an Expanded Credit Facility of up to $30 million with Squadron Medical Finance Solutions LLC.
- Interest Rate: LIBOR plus 8% (currently 10.5%), subject to a 10% floor and a 13% ceiling.
- Repayment Terms: Interest-only payments due monthly for the first 30 months; maturity concurrent with existing secured financing.
- Liquidity Impact: Additional secured financing intended to increase available capital, subject to customary closing conditions.
Material Changes and Agreements
The primary material change is the expansion of the Company's credit facility. This agreement includes a warrant issuance component:
- Warrant Terms: Upon drawing under the expanded facility, the Company will issue a warrant to Squadron to purchase 4.8 million shares of common stock at an exercise price of $2.17.
- Documentation Status: Definitive documentation is expected to be completed before the end of March 2019.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance or management commentary regarding future operational performance beyond the expectation of completing definitive documentation for the credit facility by the end of March 2019.
Risks and Contingencies: The availability of the additional $30 million financing and the issuance of the warrant are contingent upon the execution of definitive documentation and the Company drawing under the facility. The filing explicitly states that the financial results referenced in Item 2.02 are not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures for the quarter and year ended December 31, 2018, by reviewing the attached Press Release (Exhibit 99.1), as they are not listed in this 8-K text.
- Confirm the execution of definitive documentation for the $30 million credit expansion and the associated warrant issuance.
- Monitor the Company's ability to meet the 10% interest rate floor and the 30-month interest-only payment schedule.
- Assess the dilution impact of the potential 4.8 million share warrant issuance at the $2.17 exercise price.